CASE REPORT
A 42-year-old black man with known AIDS presented to the emergency department with a 1-week history of right-sided fl ank pain, with fever, chills, nonproductive cough, and dyspnea. His CD4 T cell count obtained approximately 2 months earlier was 12 cells/μL, with an HIV viral load of 253,100 copies/mL. He was being treated with efavirenz/emtricitabine/ tenofovir but stated that his medication compliance had been 
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Benjamin Shepard, DO, Dustin Tompkins, DO, Damon Baker, DO, and Jeffrey Stroup, PharmD intermittent over the past several months. He previously had been on lopinavir/ritonavir/abacavir/lamivudine, with a somewhat recent discontinuation. Due to the patient's poor CD4 count and increasing viral load, it was suspected that resistance to his current medication regimen had developed.
Upon presentation, the patient was also on a prophylactic antibiotic regimen consisting of dapsone and azithromycin. Two months earlier, he had been hospitalized for an acute febrile illness of unknown origin. At that time the patient was treated empirically for mycobacterium avium complex and histoplasmosis with ethambutol, azithromycin, and itraconazole. Th e patient reported that approximately 1 week following hospital discharge, his recurrent fevers ceased and he was back to his previous baseline, which was the case until 5 days preceding this admission.
On physical examination, he was not in any apparent distress. He was afebrile, the heart rate was 121 beats per minute, the blood pressure was 117/69 mm Hg, and the arterial blood saturation was 88% on room air. His oxygen saturation improved to 98% with 2 L/min supplemental oxygen. Fine bilateral pulmonary rhonchi were heard. No visible skin lesions were seen. A 1 cm excoriated lesion was seen at the junction of the hard and soft palate, and a 1 cm fungating mass was seen at the tip of the uvula. Th e lymph nodes were enlarged in the cervical, submandibular, axillary, and inguinal regions. Laboratory results demonstrated pancytopenia with a white blood cell count of 3.2 × 1000/mm 3 and platelets 27,000, as well as mild hyponatremia of 131 mmol/L. Th e initial arterial blood gas was pH 7.48 with a pO 2 of 65 mm Hg. Th e initial chest radiograph revealed the presence of bilateral diff use airspace and interstitial opacities, consistent with a multilobar atypical pneumonia. A computed tomography scan of the chest, abdomen, and pelvis with intravenous contrast revealed the presence of a bilateral multilobar pneumonia, diff use mesenteric edema, splenomegaly, and enlarged bilateral inguinal lymph nodes. He
Approximately 24 hours following admission, a repeat chest radiograph demonstrated increasing bilateral opacities. Th e work of breathing had increased, and 4 L/min supplemental oxygen via nasal cannula was initiated. Arterial blood gas revealed a worsening pO 2 of 59 mm Hg. His oxygen requirement further increased to 10 L/min via nonrebreather mask to achieve a saturation of 92%, and he was electively intubated.
Following transfer to the intensive care unit, the patient's highly active antiretroviral therapy (HAART) regimen was altered from efavirenz/emtricitabine/tenofovir back to lopinavir/ ritonavir/abacavir/lamivudine. Pathologic specimens from a previous lymph node biopsy revealed positive HHV-8 staining, consistent with KS. Bronchoscopy, bone marrow biopsy, and lesion biopsy were nondiagnostic, with negative staining for Pneumocystis jiroveci. All empiric antibiotic and antifungal treatments were stopped after multiple negative diagnostic studies. He was started on doxorubicin treatment once every 3 weeks. Ventilator weaning was initiated and a tracheostomy placed. Th e patient demonstrated subjective and objective responsiveness to the doxorubicin treatment, with improved pulmonary infi ltrates, decreased diff use lymphadenopathy, and clinical improvement. After 20 days he was discharged to his home without supplemental oxygen.
DISCUSSION
KS is a multicentric neoplastic process that aff ects skin, vasculature, lymphatics, and viscera. Historically, KS has been a prominent clinical feature of AIDS. Before the advent of HAART, KS was over 20,000 times more common in AIDS patients than in the general population (6) . Th e cumulative incidence of AIDS-associated KS has steadily declined since the 1980s, from 14% during the 1980s to 7% from 1990 to 1995 and 2% from 1996 to 2006 (7). Th is change is a direct refl ection of the development of HAART with the introduction of zidovudine in 1987 in addition to an increase in HIV/AIDS awareness, increased diagnosis, and the timely initiation of HAART. KS has a wide variety of clinical presentations, from mild, with minimal lymph node involvement and cutaneous manifestations, to a more fulminant form that involves skin, lymph nodes, and viscera. In more disseminated forms, the gastrointestinal tract, lymph nodes, and lung are the most common areas of disease, but there have been reports of KS involving the central nervous system and the heart as well (8) .
Our patient clearly presented with a disseminated or metastatic form of KS, with initial involvement of the lymphatics and subsequent development of rapidly progressive, fulminant pulmonary disease. While metastatic KS represents a less common disease variant, a detailed search revealed only one description of 11 patients with KS in whom cutaneous involvement was absent. In 2005, Stebbing and colleagues were the fi rst to describe an HIV-infected cohort of 5932 patients, out of which only 11 were identifi ed as having noncutaneous KS (9) . Our patient presented with AIDS clinical trial group stage T1I1S1 disease, which was noted in just 3 of the 11 patients described by Stebbing and associates, possibly indicating an infrequent presentation of an already rare disease variant. Contributing to diagnostic diffi culty is the fact that the AIDS population is especially susceptible to opportunistic as well as typical infections; lymphadenopathy and bilateral pulmonary infi ltrates are not uncommon hospital presentations. Th is case highlights the importance of maintaining an expansive diff erential and obtaining tissue for diagnostics in treatment-unresponsive conditions in HIV/AIDS patients. Equally important is immediate access to an experienced multidisciplinary team with a comprehensive knowledge and understanding of HIV/AIDS-related pathology.
